Form 144/A TechTarget, Inc. Filed by: Noreck Daniel T
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Informa TechTarget to Announce Third Quarter 2026 Financial Results; Participate in Upcoming Investor Conference
- IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
- Informa TechTarget to Integrate its Proprietary ‘Buyer Intelligence’ with Demandbase to Help Joint Customers Transform ABM Strategy and Achieve Unprecedented Outcomes
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share